Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego

Тражи се учесникФаза 3

Узраст од 2 до 11 · Оба пола · Ажурирано 5. 11. 2026. · NCT06807281

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Anaheim Clinical Trials, LLC, Anaheim
TCR Medical Corporation, San Diego

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 70 · Оба пола · Ажурирано 5. 11. 2026. · NCT06564389

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Marvel Clinical Research, Huntington Beach
Metropolis Dermatology - DTLA, Los Angeles
Northridge Clinical Trials, Northridge
и још 1

Тражи се учесникФаза 2

Узраст од 18 до 64 · Оба пола · Ажурирано 5. 11. 2026. · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Fountain Valley
Investigational Site, Los Angeles

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07003425

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Kern Research, Inc.- Site Number : 8400047, Bakersfield
Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
и још 4

Тражи се учесникОпсервациона студија

Узраст 12 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07290803

A Study Evaluating TRIV-573 in Atopic Dermatitis

Triveni Bio Site #15, Fountain Valley
Triveni Bio Site #4, Los Angeles

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 28. 10. 2026. · NCT07782333

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

First OC Dermatology, Irvine

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 72 · Оба пола · Ажурирано 29. 9. 2026. · NCT06808477

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Fountain Valley
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Sacramento
и још 2

Тражи се учесникФаза 2

Узраст од 18 до 100 · Оба пола · Ажурирано 28. 9. 2026. · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Beverly Hills
Enveda Investigative Site, Fremont
Enveda Investigative Site, San Diego
и још 3

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT07298395

The Impact of Dietary Salt on the Severity of Eczema

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Тражи се учесникФаза 4Здраве особе су добродошле

Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT07447063

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

UCSF Mt Zion Campus, San Francisco
San Francisco VA Medical Center, San Francisco

Тражи се учесникФаза 4Здраве особе су добродошле

Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT07487831

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Marvel Research, LLC, Huntington Beach
Metropolis Dermatology, Los Angeles
Dermatology Research Associates, Los Angeles
и још 4

Тражи се учесникФаза 2

Узраст од 18 до 65 · Оба пола · Ажурирано 28. 8. 2026. · NCT07599813

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Allergy and Asthma Medical Group and Research Center, San Diego

Тражи се учесникОпсервациона студија

Узраст 12 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06899204

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Integrative Skin Science and Research, Sacramento

Тражи се учесникФаза 4

Узраст 12 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT07560618

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 1, Lancaster
Inmagene Site 23, Los Angeles

Тражи се учесникФаза 2

Узраст од 18 до 74 · Оба пола · Ажурирано 12. 8. 2026. · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Encinitas
Enveda Investigative Site, Los Angeles
Enveda Investigative Site, Northridge

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT07643766

Sodium in the Skin and Atopic Dermatitis

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст 50 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06998446

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

University of California, San Diego: Dermatology Clinical Trials Unit, San Diego

Тражи се учесникФаза 1

Узраст 6 и старији · Оба пола · Ажурирано 2. 7. 2026. · NCT06504160

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

First OC Dermatology, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
California Allergy and Asthma Medical Group, Los Angeles
и још 1

Тражи се учесникФаза 2

Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT06397911

Molecular Signatures of Cutaneous Dupilumab Response

University of California, San Francisco, San Francisco

Тражи се учесникФаза 4

Узраст 18 и старији · Оба пола · Ажурирано 4. 6. 2026. · NCT05858619

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site - 7074, Corona
Galderma Investigational Site 8636, Fountain Valley
Galderma Investigational Site 8224, Fremont
и још 4

Тражи се учесникОпсервациона студија

Узраст 12 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT06988605

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Corvus Clinical Trials, South San Francisco

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT07441395

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

University of California San Diego (UCSD), La Jolla

Тражи се учесникОпсервациона студија

Сви узрасти · Жене · Ажурирано 28. 1. 2025. · NCT05938478

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Physioseq, LLC /ID# 267266, Sacramento

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 24. 1. 2025. · NCT06524635

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.